The COVID-19 Therapeutics Accelerator is a collaborative effort to research, develop and bring effective treatments to market quickly and accessibly.
Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and no proven treatments approved for use against COVID-19.
The COVID-19 Therapeutics Accelerator is a philanthropic initiative designed to coordinate R&D efforts, remove barriers to drug development and scale up treatments to address the pandemic.
We can combat COVID-19 together. Sharing knowledge and resources across governments, the private sector, academia and philanthropy can accelerate the timeline for bringing treatments to market. We are actively seeking and welcoming new partners and collaborators in this effort.
Update October 13th: Thank you for your interest in collaborating with the COVID-19 Therapeutics Accelerator. We are not accepting new proposals at this time, but please check back in the future for updates on grant opportunities.